Leaderboard

En | De
Sie sind hier: Neurologie » Alzheimer 04. September 2026
Suchen
medline.ch
Alzheimer
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3604  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 72080  
   
Fibroblast growth factors in Alzheimer's Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development.
Mol Biol Rep
Sehgal J, Bagri K, Deshmukh R.
PMID: 42690514 [PubMed - indexed for MEDLINE]


Insomnia symptoms and stress exposure interact in relation to Alzheimer's disease biomarkers.
J Neurol
Holleman J, Kåreholt I, Näsholm MS, Sørensen C, Hagman G, Aspö M, Kivipelto M, Solomon A, Sindi S.
PMID: 42690440 [PubMed - indexed for MEDLINE]


Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.
Acta Neuropathol
Mastrangelo A, Baiardi S, Ruggeri E, Bentivenga GM, Vargiu CM, Mammana A, Sbriccoli M, Polischi B, Carlà B, Capellari S, Parchi P.
PMID: 42690439 [PubMed - indexed for MEDLINE]


Alzheimer's Disease, Piezo2 Channelopathy, Piezo1 Channelopathy, and the Body-Wide Piezo2 System.
Front Biosci (Landmark Ed)
Sonkodi B.
PMID: 42690003 [PubMed - indexed for MEDLINE]


Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer's Disease.
Front Biosci (Landmark Ed)
Pupyshev AB, Ovsyukova MV, Akopyan AA, Tenditnik MV, Korolenko TA, Dubrovina NI, Tikhonova MA.
PMID: 42689975 [PubMed - indexed for MEDLINE]


Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases.
RSC Adv
Kaur R, Lang DK, Sood A, Singh TG, Chandrasekaran B, Al-Sha'er MA.
PMID: 42689220 [PubMed - as supplied by publisher]


Shared Metabolic-Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum.
Aging Med (Milton)
Yao SY, Du MQ, Lin LX, Kang XH, Jiang DY, Peng Y.
PMID: 42688951 [PubMed - as supplied by publisher]


Nicotinic Acetylcholine Receptor Modulation Distinguishes Clinical Benefits of Galantamine in Alzheimer's Disease.
Sage Open Aging
Svintozelskiy PV, Wahlert AJ, Harrod C, Kay DG, Grady KP, Grossberg GT.
PMID: 42688663 [PubMed]


Bridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's disease.
Alzheimers Dement (Amst)
Pang Y, Chen L, Dodge HH, Zhou J.
PMID: 42688514 [PubMed]


Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions.
Front Neurol
Zupan M, Prelog PR, Kramberger MG, Frol S.
PMID: 42688139 [PubMed - indexed for MEDLINE]


Multi-omics integration identifies a gut-microbiota-associated plasma metabolite signature for alzheimer disease diagnosis and metabolic pathway targeting.
Front Pharmacol
Chen J, Chen X, Yu W, Chen T, Liu Z, Hu J.
PMID: 42688072 [PubMed]


Temporal trends in the prevalence of Alzheimer's disease, 1980-2024: a systematic review and meta-analysis.
Front Public Health
Hu M, Sun Z, Mao D, Tian X, Shang Q.
PMID: 42688049 [PubMed - indexed for MEDLINE]


Association between Internet Use for Health Information and Self-reported Alzheimer's Disease Diagnosis among Older Adults in the United States: Racial and Gender Disparities.
Res Sq
Zeidan HM, Shah GH, Zeidan IH, Samawi HM, Jones JA.
PMID: 42687965 [PubMed]


Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects.
Inflammopharmacology
Sharma V, Vashisht K, Choudhary G, Choudhay V, Bhatia V, Ashawat MS, Baldi A, Kushawaha SK.
PMID: 42686974 [PubMed - as supplied by publisher]


Memory, social cognition, and beyond: Neuropsychological markers differentiating Alzheimer's disease and frontotemporal dementia.
J Alzheimers Dis
Freitag JM, Konen FF, Heck J, Jahn K, Groba S, Klietz M, Skripuletz T, Wegner F, Schulze Westhoff M, Schröder S.
PMID: 42684971 [PubMed - as supplied by publisher]


Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.
Clin Chem Lab Med
Agnello L, Pilotto A, Gaetani L, Bellomo G, Bessi V, Bozzali M, Cagnin A, Labate A, Massa F, Moda F, Monastero R, Musso G, Piccoli T, Sancesario G, Parnetti L, Padovani A, Ciaccio M.
PMID: 42683894 [PubMed - as supplied by publisher]


Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis.
J Vis Exp
Han P, Dong P, Zhou Y, Zhang L, Mahomed O.
PMID: 42683892 [PubMed - indexed for MEDLINE]


A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias.
Alzheimers Dement
Dubbelman MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, Azar M, Babulal GM, Bell TR, Bernard MA, Boza-Calvo C, Briggs AQ, Bubu OM, Cuevas HE, Dowling NM, Esiaka DK, Fausto BA, de Oliveira FF, Franz CE, Furlano JA, Gonzalez-Corona C, Guest MA, Gupta VB, Gupta VK, Jackson D, Joyce JL, Kann MR, Kremen WS, Lee A, Martinez JE, Masurkar AV, McLin MA, Resende EPF, Rahemi Z, Renfro BC, Aliberti MJR, Shagalow S, Slachevsky A, Talarico JNS, Trani JF, Van Hulle C, Waltrip L, Wandera SO, Windon CC, Yassuda MS, Moretti DV, Kuhn E, Butterbrod E, Gifford KA, Sikkes SAM, Castilhos RM, Nosheny R, Stites SD, a collaboration of the Alzheimer's Association International Society to Advance Alzheimer's Research and Therapy Subjective Cognitive Decline and Diversity and Disparities Professional Interest Areas.
PMID: 42683545 [PubMed - indexed for MEDLINE]


The highest clinical trial failure rate for any disease in modern medicine: How both amyloid- and non-amyloid-targeting therapies failed to alter disease course in Alzheimer's disease.
Free Neuropathol
Guth MAS.
PMID: 42683436 [PubMed]


From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease.
Alzheimers Dement (Amst)
Liu J, Xu C, Wang Y, Zhang J, Hui R, Lv W, Xu A, Dang Y, Su S, Zhao H, Gao Y, Zhang J.
PMID: 42683384 [PubMed]


   
   Artikel 1 - 20 / 72080    Seite 1 von 3604  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1